FDA approval on the Phase I-II study is official. Let's hope it goes well. Link. It's very limited, but, frankly, any bone thrown from the FDA in this market is a big deal. If enrollment goes smoothly and Phase I goes well, expect major movement in the share price (I am assuming that it will be reinstated well before any study results are released).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.